NCT01227291

SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg

Study With SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With IOP >= 21 mm Hg.

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Sylentis, S.A. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to evaluate the tolerance and effect on unmedicated subjects with elevated IOP.

Detailed description

The aim of this study is to evaluate the tolerance and effect on unmedicated subjects with elevated IOP. An unmedicated subject is considered a person without any IOP/glaucoma treatment at least one month before recruitment.

Conditions

• Glaucoma
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	SYL040012	SYL040012 ophthalmic drops, daily single dose administration

Timeline

• Start date: 2010-10-01
• Primary completion: 2012-03-01
• Completion: 2012-09-01
• First posted: 2010-10-25
• Last updated: 2012-09-27

Locations

2 sites across 1 country: Spain